Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Glory Health Industry Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Glory Health Industry şirketinin toplam hissedar öz sermayesi CN¥13.7B ve toplam borcu CN¥22.1B olup, bu da borç-öz sermaye oranını 161.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥55.1B ve CN¥41.4B dir.

Anahtar bilgiler

161.3%

Borç/özkaynak oranı

CN¥22.13b

Borç

Faiz karşılama oranı	n/a
Nakit	CN¥210.06m
Eşitlik	CN¥13.72b
Toplam yükümlülükler	CN¥41.36b
Toplam varlıklar	CN¥55.08b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 84R 'nin kısa vadeli varlıkları ( CN¥28.7B ) kısa vadeli yükümlülüklerini ( CN¥28.9B ) kapsamıyor.

Uzun Vadeli Yükümlülükler: 84R şirketinin kısa vadeli varlıkları ( CN¥28.7B ) uzun vadeli yükümlülüklerini ( CN¥12.4B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 84R 'nin net borç/öz sermaye oranı ( 159.8% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 84R 'nin borç/öz sermaye oranı son 5 yılda 167.5% seviyesinden 161.3% seviyesine düştü.

Borç Kapsamı: 84R 'nin borcu işletme nakit akışı ( 0.5% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 84R şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.

Glory Health Industry Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 59% undervalued after recent price drop

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought €171k worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin